title: Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study.
abstract: OBJECTIVE
  Data on the association of aortic root diameter (ARD), as assessed by echocardiography, with incident cardiovascular morbidity and mortality in the general population, are scanty and limited to elderly individuals. Thus, we investigated the value of ARD in predicting cardiovascular events in the Pressioni Arteriose Monitorate E Loro Associazioni population.
  
  
  METHODS
  At entry, 1860 participants (mean age 50 ± 14, 50.6% men) underwent diagnostic tests including laboratory investigations, office and out-of-office blood pressure (BP) measurements (home and 24-h ambulatory BP monitoring), and echocardiography. ARD was measured at the level of Valsalva's sinuses and indexed to body surface area and height.
  
  
  RESULTS
  Over a follow-up of 148 months, 137 nonfatal or fatal cardiovascular events were documented. After adjustment for age, sex, BP, fasting blood glucose, total cholesterol, smoking status, previous cardiovascular disease, and use of antihypertensive drugs, ARD/height [hazard ratio for 1 unit increase = 2.62, 95% confidence interval (CI) 1.19-5.75, P = 0.01], but not absolute ARD (hazard ratio 1.44, 95% CI 0.89-2.39, P = 0.13) neither ARD/body surface area (hazard ratio 2.09, 95% CI 0.96-4.55, P = 0.06) predicted the increased risk of cardiovascular events. The association between left ventricular hypertrophy and AR dilatation was a stronger predictor of cardiovascular prognosis than left ventricular hypertrophy alone.
  
  
  CONCLUSIONS
  Our results for the first time show that ARD indexed to height is predictive of incident nonfatal and fatal cardiovascular events among middle-aged individuals in the community and support the view that assessment of ARD in addition to left ventricular mass may refine cardiovascular risk stratification and preventive strategies in the general population.
authors.affiliation: aDepartment of Health Science, University of Milano-Bicocca bIstituto Auxologico Italiano IRCCS cDepartment of Clinical Sciences and Community Health University of Milano and Fondazione Ospedale Maggiore Policlinico, Milan, Italy dUniversity Clinical Hospital Centre 'Dragisa Misovic', Belgrade, Serbia eIRCCS Multimedica, Sesto San Giovanni, Milan, Italy.
authors.forename: Cesare
authors.initials: C
authors.lastname: Cuspidi
authors.forename: Rita
authors.initials: R
authors.lastname: Facchetti
authors.forename: Michele
authors.initials: M
authors.lastname: Bombelli
authors.forename: Annalisa
authors.initials: A
authors.lastname: Re
authors.forename: Matteo
authors.initials: M
authors.lastname: Cairoa
authors.forename: Carla
authors.initials: C
authors.lastname: Sala
authors.forename: Marijana
authors.initials: M
authors.lastname: Tadic
authors.forename: Guido
authors.initials: G
authors.lastname: Grassi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Mancia
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001011:Aorta / Q000000981:diagnostic imaging / Q000473:pathology*; D018660:Blood Pressure Monitoring, Ambulatory; D001827:Body Height; D001830:Body Surface Area; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000401:mortality; D004452:Echocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D011379:Prognosis; D016016:Proportional Hazards Models; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents